Tempest Therapeutics, Inc.
A biotechnology company developing novel oral therapeutics for solid tumors. Its diverse pipeline of small molecule compounds that directly target tumor cells, modulate the immune system to kill cancer cells, or a combination of both, are being developed for hepatocellular carcinoma, cholangiocarcinoma, renal carcinoma, and other cancers. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 17 |
Founded | 2011 |
Financials | |
|---|---|
Market Capitalization | 49.54M |
Revenue | |
Operating Income | -29.55M |
Operating Margin | |
Net Income | -29.76M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4175 / 5373 |
Sector : Healthcare | 594 / 1144 |
Industry : Biotechnology | 243 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4538 / 5565 |
Sector : Healthcare | 818 / 1182 |
Industry : Biotechnology | 451 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4043 / 5436 |
Sector : Healthcare | 576 / 1164 |
Industry : Biotechnology | 249 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4850 / 5330 |
Sector : Healthcare | 978 / 1174 |
Industry : Biotechnology | 508 / 667 |